Tag: medicine
Journey Clinical raises $3M to allow psychotherapists to prescribe psychedelics
Psychedelics companies are all the rage right now. Compass Pathways is working with the magic mushroom compound psilocybin to treat depression. It’s has raised $290 million in total. Atai Life Sciences — backed by PayPal co-founder Peter Thiel — brought in $258 million from its IPO. In the tech space,…
Read More
Southeast Asia “omnichannel” health startup Doctor Anywhere gets $88M SGD
Doctor Anywhere, a startup that takes an “omnichannel” approach to healthcare, announced today it has raised $88 million SGD (about $65.7 million USD) in Series C funding. The round was led by Asia Partners, with participation from Novo Holdings, Philips and OSK-SBI Partners. It also included returning investors EDBI, Square…
Read More
This startup just created a fast, accurate COVID test that only needs saliva and links to an app
We’re entering a phase in the COVID-19 pandemic where transmission is going to go through the roof because of the Delta variant. But as vaccinations ramp up around the world, the main cost to society now will not be the health services being overwhelmed, but mass disruption to businesses as…
Read More
As clinical guidelines shift, heart disease screening startup pulls in $43M Series B
Cleerly Coronary, a company that uses A.I powered imaging to analyze heart scans, announced a $43 million Series B funding this week. The funding comes at a moment when it seems that a new way of screening for heart disease is on its way. Cleerly was started in 2017 by…
Read More
Mobile dialysis startup eyes human trials in 2022 following encouraging animal study
This past year, three sheep in Canada have been wearing their kidneys on their sleeves. Or more aptly, in jackets on their fluffy backs. These three sheep are part of an ongoing animal study run by the Buffalo, New York-based startup Qidni Labs, a company pursuing waterless and mobile blood…
Read More
Serimmune launches new immune response mapping service for COVID-19
Immune intelligence startup Serimmune hopes to better understand the relationship between antibody epitopes (the parts of antigen molecules that bind to antibodies) and the SARS-CoV-2 virus. The company’s proprietary technology, originally developed at UC Santa Barbara, provides a new and specific way of mapping the entire array of an individual’s…
Read More